GlassScriptPhysician profile
Steven J Weiss
NPI 1841269867
$1,360.12
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $26.26 · 2021: $249 · 2022: $334 · 2023: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421 · Education: $74.75.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $421.03 |
| Education | $74.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $564.54 | 2019-2023 | Tezspire |
| Optinose US, INC. | $225.58 | 2019-2023 | |
| Genzyme Corporation | $200.77 | 2019-2023 | |
| Amgen INC. | $113.94 | 2022 | |
| Alk-Abello, INC | $106.12 | 2022 | |
| Sanofi-Aventis U.S. LLC | $74.75 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $44.25 | 2023 | Dupixent |
| Glaxosmithkline, LLC. | $30.17 | 2021-2023 | Nucala |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Weiss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.